These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9640070)

  • 1. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].
    Prusiński A; Król F
    Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study.
    Sargent J; Kirchner JR; Davis R; Kirkhart B
    Neurology; 1995 Aug; 45(8 Suppl 7):S10-4. PubMed ID: 7644079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
    Cutler N; Mushet GR; Davis R; Clements B; Whitcher L
    Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
    Tepper SJ; Cochran A; Hobbs S; Woessner M
    Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
    Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
    Boureau F; Kappos L; Schoenen J; Esperanca P; Ashford E
    Int J Clin Pract; 2000 Jun; 54(5):281-6. PubMed ID: 10954953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
    Salonen R; Ashford EA; Gibbs M; Hassani H
    Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
    Visser WH; Burggraaf J; Muller LM; Schoemaker RC; Fowler PA; Cohen AF; Ferrari MD
    Clin Pharmacol Ther; 1996 Oct; 60(4):452-60. PubMed ID: 8873693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.